DataMeds AI Inc. Common Stock (MEDS)
Stock · NASDAQ · Health Care
$2.67as of 10/16/2026
Price chart
Active signals
MEDS Signal Track Record
How signals performed across all stocks →What MEDS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 8 | -21.1% | 25% | October 1, 2026 |
| Bollinger Band Breakdown | 4 | -33.1% | 0% | August 7, 2026 |
| Any 20-session window (baseline) | -26.4% | 22% |
Computed by MarketWall from daily closing prices since December 5, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MEDS
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubR…
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- Website
- wellgisticshealth.com/
Fundamentals
- 1-day range
- $2.65$2.88
- Market cap
- $7.52M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-48.32
- Dividend yield
- —
- Beta
- -1.07
- Avg. volume
- 6.40M
DataMeds AI Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MEDSDataMeds AI Inc. Common Stock$2.63▼ 7.72%Market cap $7.52MP/E —$0.8225$12.31
- COSMCosmos Health Inc. Common Stock$0.331▼ 1.49%Market cap $13.72MP/E —$0.1616$1.26
- HKPDCellyan Biotechnology Co. Ltd Class A Ordinary Shares$0.11▲ 0.00%Market cap $16.93MP/E —$0.095$1.72
- ZSTKZeroStack Corp. Common Stock$4▼ 5.21%Market cap $30.78MP/E —$1.32$20.45
- NUSNu Skin Enterprises Inc. Common Stock$5.14▼ 1.34%Market cap $251.98MP/E 4.30$4.45$11.67
- HLFHerbalife Ltd. Common Shares$14.6▲ 0.21%Market cap $1.19BP/E 9.24$7.56$20.4
- CAHCardinal Health Inc. Common Stock$254.06▲ 0.14%Market cap $55.66BP/E 33.97$152.46$258.3
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MEDS DataMeds AI Inc. Common Stock | $7.52M | — | $2.63 | ▼ 7.72% | $0.8225$12.31 |
| COSM Cosmos Health Inc. Common Stock | $13.72M | — | $0.331 | ▼ 1.49% | $0.1616$1.26 |
| HKPD Cellyan Biotechnology Co. Ltd Class A Ordinary Shares | $16.93M | — | $0.11 | ▲ 0.00% | $0.095$1.72 |
| ZSTK ZeroStack Corp. Common Stock | $30.78M | — | $4 | ▼ 5.21% | $1.32$20.45 |
| NUS Nu Skin Enterprises Inc. Common Stock | $251.98M | 4.30 | $5.14 | ▼ 1.34% | $4.45$11.67 |
| HLF Herbalife Ltd. Common Shares | $1.19B | 9.24 | $14.6 | ▲ 0.21% | $7.56$20.4 |
| CAH Cardinal Health Inc. Common Stock | $55.66B | 33.97 | $254.06 | ▲ 0.14% | $152.46$258.3 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- DataMeds AI Enters IP License Agreement With Reboot Health AI On Oct 13, 2026; Reboot Grants DataMeds AI Exclusive License To Patents And Health AI Platform In U.S.; Reboot To Receive Portion Of DataMeds AI's Adj Gross Revenue; Co To Issue Reboot 666,667 Shares As IP License Stock Componentbenzinga · 10/16/2026
- Top stock movements in today's session.ChartMill · 10/8/2026
- DataMeds AI Files DBAs For 'DataMeds SI' And 'Corexa Health SI'Benzinga · 10/5/2026
- DataMeds AI Corexa Pharmacy Surpasses $1 Million in Monthly Revenue as Sales Rise 66%Yahoo · 10/1/2026
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 10/1/2026
- DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly RevenueYahoo · 10/1/2026
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga · 10/1/2026
- Axe Compute Just Sold Its Cancer Business to Become an AI StockYahoo · 9/28/2026
- DataMeds AI Launches Health Lives Here App Focused on GLP-1 Telehealth and Pharmacy ServicesYahoo · 9/28/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
MEDS hits $1M monthly Corexa revenue, unveils health app
DataMeds AI reported that its Corexa Pharmacy generated over $1 million in revenue for the month, reflecting a 66% increase in sales. The company also introduced the Health Lives Here app, which targets GLP‑1 telehealth and pharmacy services. The announcements coincided with a reported rise in the stock price following the app launch.
MEDS hits $1M monthly Corexa revenue, unveils health app. DataMeds AI reported that its Corexa Pharmacy generated over $1 million in revenue for the month, reflecting a 66% increase in sales. The company also introduced the Health Lives Here app, which targets GLP‑1 telehealth and pharmacy services. The announcements coincided with a reported rise in the stock price following the app launch.